相关产品推荐更多 >

小鼠H2-D1重组蛋白H2-D1;H-2 class I histocompatibility antigen;D-D alpha chain;H-2D(D)Mouse H-2 class I histocompatibility antigen, D-D alpha chain(H2-D1)蛋白
¥1836
Recombinant-Helicobacter-pylori-Flagellar-biosynthetic-protein-FliQfliQFlagellar biosynthetic protein FliQ
¥9562
人LGR5重组蛋白Leucine-rich repeat-containing G-protein coupled receptor 5;G-protein coupled receptor 49;G-protein coupled receptor 67;G-protein coupled receptor HG38;LGR5;GPR49, GPR67Human Leucine-rich repeat-containing G-protein coupled receptor 5(
¥3720
小鼠Il13ra1重组蛋白IL-13 receptor subunit alpha-1;IL-13R subunit alpha-1;IL-13R-alpha-1;IL-13RA1;Interleukin-13-binding protein;Novel cytokine receptor 4(NR4);CD213a1;Il13ra1;Il13r, Il13raMouse Interleukin-13 receptor subunit alpha-1(Il13ra1)蛋白
¥588
Recombinant-Pseudomonas-putida-Protein-CrcB-homologcrcBProtein CrcB homolog
¥9884
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
见说明书
- 保质期:
见说明书
- 英文名:
Recombinant Tomato yellow leaf curl Sardinia virus Protein C4 (C4, L4)
- 库存:
99
- 供应商:
武汉华美生物/CUSABIO
- 规格:
20ug/100ug/1mg
C4蛋白|Recombinant Tomato yellow leaf curl Sardinia virus Protein C4 (C4, L4)|大肠杆菌/毕赤酵母/哺乳动物细胞/杆状病毒-昆虫细胞/无细胞 五大表达系统
Uniprot ID:P38612
别名:C4; L4Protein C4; 10.9 kDa protein; Protein L4
种属:Tomato yellow leaf curl Sardinia virus (isolate Spain-1) (TYLCSV)
氨基酸序列:参见官网
微信ID: Cusabio01 电话: 027-87939808
详情请登录:www.cusabio.cn
| 华美生物︱YOUR GOOD PARTNER IN BIOLOGY RESEARCH! | |
| 武汉华美生物工程有限公司成立于2007年12月,是一家集科研、生产、销售为一体的生物高新技术企业。并形成了以CUSABIO为品牌的ELISA试剂盒、外泌体提取试剂盒、蛋白、抗体等多种优质产品,远销欧美日德等九十多个国家。 推荐您微信关注华美官方公众号,方便查询产品,同时获取生命科学更新资讯! |
|
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Purification and Functional Characterization of C4b-Binding Protein (C4BP)
C4b-binding protein (C4BP) is a soluble, 570 kDa large glycoprotein, present in plasma at a concentration of approximately 200 mg/L. C4BP is the main inhibitor of the classical and lectin pathways of complement, where it controls C4b-mediated
Complement C4 Protein and DNA Typing Methods
of C4 genes; (ii) at the DNA sequence level by determining variability in the coding sequence, as well as by analyzing restriction fragment length polymorphisms (RFLPs) in introns and flanking regions; (iii) at the protein level by electrophoretic
Human Complement Components C4A and C4B Genetic Diversities: Complex Genotypes and Phenotypes
and order or configuration of these genes in the MHC. Finally, methods to assess the degree of polymorphism in C4A and C4B proteins and whether low protein levels of plasma C4 may be caused by low C4 gene dosages and/or by mutant C4 genes.
技术资料暂无技术资料 索取技术资料






